Work

Phase II Trial of Romidepsin, FK228, in Cutaneous and Peripheral T-Cell Lymphoma: Clinical Activity and Molecular Markers.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.2469.2469

Authors: Richard L. Piekarz, Robin Frye, Maria Turner, John Wright, Steven Allen, Mark H. Kirschbaum, Jasmine Zain, Miles Prince, Laura Hutchins, Louise C. Showe, William D. Figg, Tito Fojo, Susan E. Bates, for All Collaborators

Institutions: National Cancer Institute, Center for Cancer Research, National Institutes of Health, North Shore University Hospital, City Of Hope National Medical Center, City of Hope, Peter MacCallum Cancer Centre, University of Arkansas at Little Rock, The Wistar Institute

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2558455860

FWCI: 3.178

Cites:

Cited by: 11

Related to: 10